Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management
Frank Bridoux(Université de Poitiers), Christophe Sirac(Centre National de la Recherche Scientifique), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Florent Di Meo(Inserm), Patrick Trouillas(Inserm), Vincent Javaugue(Université de Poitiers), Nathalie Quellard(Université de Poitiers), Amélie Bonaud(Centre National de la Recherche Scientifique), Marie‐Annick Clavel(University of Southern Denmark), Michel Cogné(Centre National de la Recherche Scientifique), Sébastien Bender(Centre National de la Recherche Scientifique), Céline Debiais-Delpech, Pièrre Aucouturier(Sorbonne Université), Jean‐Michel Goujon(Centre Hospitalier Universitaire de Poitiers), Jean‐Marc Gombert(Laboratory of Molecular Genetics), Jean‐Paul Fermand(Sorbonne Université), Fannie Leroy, Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges)
Cited by 82
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Stabilizing and Modulating Color by Copigmentation: Insights from Theory and Experiment
|Chemical Reviews|2016|625